AU1608400A - Method of treating arthritis with human parvovirus b19 antigens or antibodies against same - Google Patents

Method of treating arthritis with human parvovirus b19 antigens or antibodies against same

Info

Publication number
AU1608400A
AU1608400A AU16084/00A AU1608400A AU1608400A AU 1608400 A AU1608400 A AU 1608400A AU 16084/00 A AU16084/00 A AU 16084/00A AU 1608400 A AU1608400 A AU 1608400A AU 1608400 A AU1608400 A AU 1608400A
Authority
AU
Australia
Prior art keywords
antigens
antibodies against
treating arthritis
human parvovirus
against same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU16084/00A
Inventor
Jennifer R. Bostic
Scott Koenig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MedImmune LLC
Original Assignee
MedImmune LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MedImmune LLC filed Critical MedImmune LLC
Publication of AU1608400A publication Critical patent/AU1608400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14211—Erythrovirus, e.g. B19 virus
    • C12N2750/14222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14211—Erythrovirus, e.g. B19 virus
    • C12N2750/14234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU16084/00A 1998-11-10 1999-11-04 Method of treating arthritis with human parvovirus b19 antigens or antibodies against same Abandoned AU1608400A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10784898P 1998-11-10 1998-11-10
US60107848 1998-11-10
PCT/US1999/026150 WO2000027431A1 (en) 1998-11-10 1999-11-04 Method of treating arthritis with human parvovirus b19 antigens or antibodies against same

Publications (1)

Publication Number Publication Date
AU1608400A true AU1608400A (en) 2000-05-29

Family

ID=22318804

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16084/00A Abandoned AU1608400A (en) 1998-11-10 1999-11-04 Method of treating arthritis with human parvovirus b19 antigens or antibodies against same

Country Status (2)

Country Link
AU (1) AU1608400A (en)
WO (1) WO2000027431A1 (en)

Also Published As

Publication number Publication date
WO2000027431A1 (en) 2000-05-18

Similar Documents

Publication Publication Date Title
AU1462300A (en) Human pan-hcv human monoclonal antibodies
EP0831880A4 (en) Antibody and antibody fragments for inhibiting the growth of tumors
ZA966240B (en) Methods for treatment of allergic asthma.
PT1818343E (en) Antibodies against human il-12
AU1559895A (en) Antisense oligonucleotides specific for stk-1 and method for inhibiting expression of the stk-1 protein
AU1704099A (en) Monoclonal human natural antibodies
EP0675534A3 (en) SOI substrate and method of producing the same.
AU7676300A (en) Human anti-adipocyte monoclonal antibodies and their use
AU6407094A (en) Method of treating tumors with antibodies
AU3374699A (en) Methods of preparing and using electrostatically treated fluids
AU1697197A (en) Immunoconjugate for the treatment of aids
AU3444899A (en) Method for the rapid determination of bacteria
AU4393497A (en) Method for the sterilization of biological materials
AU1538497A (en) Anti-gp46 antibodies and fragments thereof and their use
EP0749445A4 (en) Antibodies which bind the g-csf receptor extracellular domain and methods of treatment
EP0977590A4 (en) Human monoclonal antibodies
EP0845712A4 (en) Pigment composition for liquid toner, method of manufacturing the same and liquid toner manufacturing method
NO981822L (en) Use of the GAX protein for the treatment of cancer
HRP970224A2 (en) TREATMENT OF ASTHMA WITH TNFR-Ig
AU2643495A (en) Assay for pathogenicity of anti-dna antibodies
AU1608400A (en) Method of treating arthritis with human parvovirus b19 antigens or antibodies against same
IT1282937B1 (en) APPARATUS FOR THE TREATMENT OF GLASSES, CUPS AND SIMILAR
IL117722A0 (en) Method for the microbial decontamination of blood platelets
ZA969315B (en) Processes and intermediates for the preparation of ziprasidone.
AU1940800A (en) Combination therapy for the treatment of sepsis

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase